This is a new senior role within King’s Commercialisation Institute (KCI) for accelerating the commercial translation and impact delivery arising from the university’s life science research.  The post will support the Director of KCI in leading and managing the commercial assessment, prioritization and management of selected research technologies alongside their respective principal investigators (PI’s).  The objective is to enhance the development and commercial prospects for technologies by creating compelling investment propositions so private and industrial investors engage to accelerate product development and achieve commercial impact.

The technologies which the post will engage cover human medical therapeutics, diagnostics, medtech and digital health.

The post holder must have relevant industrial experience having had responsibilities in managing the transition of research technologies into development and in successfully negotiating business and investor transactions.

 The post holder will help PIs and other team members to develop and implement robust and comprehensive business cases that align with and are compelling to the needs of investors and industry.

The role profile is available on the KCL website at

Interviews are provisionally scheduled to be held in May/June 2018

Post duration:    Indefinite contract.


Salary:    The basic salary will be negotiable, plus £2,323 per annum London Allowance.

Contact Information: To apply for this position or discuss further, please contact our recruitment partner Ann Gales at

Application forms must also be in word format, not PDF.

Other Information:

The closing date for receipt of applications is midnight on Monday May 7th 2018. 

Equality of opportunity is College policy